«Evermine50» stent system
The Evermine50™ is the world’s thinnest (ultrathin) coronary stent with everolimus elution, with a thickness of 50 μm (0.050 mm), designed to minimize vessel irritation and accelerate endothelialization. With a hybrid cell design and BioPoly™ bioresorbable polymer, it offers an ideal balance of flexibility and radial strength for safe angioplasty and excellent healing.
Advantages
- 50 μm (0.050 mm) thickness — the thinnest in the world, minimizes vascular injury.
- PLLA/PLGA polymer that is absorbed after everolimus release, without long-term inflammation
- Proven drug with rapid release, reduces in-stent hyperplasia
- Closed cells at the edges (better support) + open in the middle (allows side branch access).
- 7 mm tapered tip that acts as a micro-catheter for easy lesion entry
Use
BioMime is used for the treatment of patients with de novo coronary artery disease in native coronary vessels.
Vessel criteria: Diameter 2.25–3.50 mm, lesion length 8–48 mm (compatible with 2.00–4.50 mm stent diameter).
Particularly suitable for:
Very long lesions (30–56 mm) with BioMime Morph (with an average length of 45.54 mm in clinical use).
Tortuous vessels due to high flexibility.
Cases requiring side branch access.
Deployment: Rapid Exchange delivery system, 9 ATM nominal pressure, 16 ATM rated burst pressure.
